Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.87 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.56 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10724300 | 1.00 | ACHE (0.87) | ACHEEPHX1EPHX2TDP1 | |
| SCHEMBL6984631 | 1.00 | ACHE (0.87) | ACHEEPHX1EPHX2TDP1 | |
| SCHEMBL13700681 | 0.98 | ACHE (0.90) | ACHEEPHX1EPHX2TDP1 | |
| SCHEMBL8801572 | 0.98 | ACHE (0.83) | ACHEEPHX1EPHX2TDP1 | |
| SCHEMBL27051138 | 0.95 | ACHE (0.90) | ACHEEPHX1EPHX2 | |
| SCHEMBL14891267 | 0.95 | ACHE (0.90) | ACHEEPHX1EPHX2 | |
| SCHEMBL27051136 | 0.95 | ACHE (0.90) | ACHEEPHX1EPHX2 | |
| SCHEMBL10897404 | 0.93 | ACHE (0.81) | ACHEEPHX1EPHX2 | |
| SCHEMBL9693989 | 0.93 | ACHE (0.81) | ACHEEPHX1EPHX2 | |
| SCHEMBL5245046 | 0.93 | ACHE (1.00) | ACHEEPHX1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180015120-A1 | Self-assembling monomers and oligomers as surface-modifying endgroups for polymers | DSM IP ASSETS BV (NL) | 2018-01-18 | — | — | US | disclosed |
| WO-2008059014-A2 | ANTITUBERCULOSIS AGENTS WITH ALKYLIDENE OR ALKYL SIDE CHAIN | UNIVERSIDAD DE SALAMANCA (ES) | 2008-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180015120-A1 | Self-assembling monomers and oligomers as surface-modifying endgroups for polymers | MLX, SRRM2, LIMA1 | ACHE 2356/4885EPHX1 901/4885EPHX2 623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.